Novartis Partners with Generate in $1B Biotech Deal
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
- Latest
- Trending
Novartis and Generate forge $1B+ deal to innovate protein therapeutics using generative AI technology.
Connect Biopharma has appointed James Zuie-chin Huang to its Board of Directors. Huang brings over 30 years of biotech experience ...
Learn how adopting technological tools and social media can enhance health, safety, social life, and quality of life. Stay active ...
GSK's acquisition of Aiolos Bio expands respiratory treatment options, introducing AIO-001, a promising new treatment for asthma patients.
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.